Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: AVIR) Delayed: 5.25 -0.43 (7.57%)
Previous Close $5.68    52 Week High $2.00 
Open $5.64    52 Week Low $1.15 
Day High $5.66    P/E N/A 
Day Low $5.25    EPS $0.00 
Volume 271,933